Multiple types of cancers have been associated with elevated levels of IGFs. These include breast cancer, prostate cancer, colorectal cancer, and lung cancer. Research has shown that high plasma levels of IGF-1 are correlated with an increased risk of these cancers, suggesting that IGF signaling plays a significant role in their development and progression.
